1256585-04-2: Alectinib M4 Metabolite
Alectinib M4 Metabolite (CAS No: 1256585-04-2) is a major metabolite of Alectinib that is a small-molecule ALK inhibitor used for the treatment of patients with ALK-positive unresectable, recurrent/advanced Non-small cell lung cancer.
Additional information on CAS 1256585-04-2
9-ethyl-8-(4-((2-hydroxyethyl)amino)piperidin-1-yl)-6, 6-dimethyl-11-oxo-6, 11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
Sato-Nakai, Mika, et al. “Metabolites of Alectinib in Human: Their Identification and Pharmacological Activity.” Heliyon, vol. 3, no. 7, July 2017, p. e00354, https://doi.org/10.1016/j.heliyon.2017.e00354.
Other products related to alectinib
|CAS No.||Name of Impurity||Parent Drug||Catalogue No.|